Launch of Pan-European Commission on Health and Sustainable Development

On 26 August, the WHO Regional Office for Europe launched the Pan-European Commission on Health and Sustainable Development.

The scope of the Pan-European Commission is to revisit policy priorities within the context of pandemics. With the aim of establishing consensus on these proposals, the Pan-European Commission endeavours to frame health and social care as key societal and political priorities for sustainable development and social cohesion across 53 Member States in the Euro Region.

Key points

WHO Regional Director for Europe Dr Hans Kluge highlighted the need to address health as a political imperative under the auspices of the Sustainable Development Goals in order to increase the resilience of pertinent systems.
Appointed Commission chair Professor Mario Monti expressed his concern about the paralysing inequalities exacerbated by the pandemic and lauded the progressive establishment of the high-level Pan-European Commission as a means of consolidating sustainable development.
Chaired by Prof. Mario Monti, the Pan-European Commission shall comprise former heads of states and governments, renowned scientists and economists, heads of healthcare and social care entities and distinguished stakeholders from business and financial institutions.

The Commission’s first deliverable shall be a comprehensive report finalised by September 2021. With the support of a Scientific Advisory Board, the document shall comprise a series of reviewed evidence submitted by researchers, allied health care professionals and scientific communities in the pan-European region

This initiative aims to assess the various health system responses regarding the fight against COVID-19 and propose recommendations to bolster their resilience.

Date: 10/09/2020 | Tag: | News: 1116 of 1626

All news

News

05/11/2024
"In silico trials: an updated SWOT Analysis" released by In Silico World

The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies. -Read more-

31/10/2024
In the literature: October 2024 highlights

Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter! -Read more-

31/10/2024
Joint motion for a resolution to revise the Medical Devices Regulation

The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector. -Read more-

31/10/2024
EU Budget for 2025 Prioritizes Research, Health, Education, and Climate Action

The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the European Commission's initial proposal of around €199.76 billion. -Read more-

More news